Showing 1216 Results
NPC President Dan Leonard Speaks on Value Frameworks at BioNJ
As our health care system shifts from a focus on volume to value, a key question emerges: Who gets to define value? National Pharmaceutical Council (NPC) President Dan Leonard and other health…
How Are Stakeholder Views Incorporated into Value Assessment Frameworks? Watch NPC's New Video
NPC's animated informational video explains how different organizations are trying to consider patient viewpoints through the development of value assessment frameworks.
Assessing Value: Promise and Pitfalls Conference Summary Report
At NPC's conference, Assessing Value: Promise and Pitfalls, top experts in their fields united to discuss value assessment as it impacts payers, patients, providers and pharmaceutical innovators.
Comparison of Value Assessment Frameworks Using the National Pharmaceutical Council’s Guiding Practices for Patient-Centered Value Assessment
NPC worked with The Lewin Group to conduct an independent analysis of the extent to which five major value assessment frameworks address or align with NPC’s Guiding Practices for Patient-Centered…
Engaging With ICER: National Psoriasis Foundation Opens Up on Value Assessment
NPC President Dan Leonard chatted with Leah Howard, Vice President of Government Relations and Advocacy, National Psoriasis Foundation, about value assessment frameworks and how her organization is…
NPC’s Dr. Jennifer Graff Testifies Before FDA on Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Devices
NPC Vice President for Comparative Effectiveness Research Jennifer Graff, PharmD, highlighted two key issues in her testimony at the Food and Drug Administration public hearing on manufacturer…
Can We Assess the Value of Personalized Medicine in Treating Cancer?
NPC President Dan Leonard spoke with Dr. Amy Miller, EVP, Personalized Medicine Coalition, about how targeted medicines will be considered in value assessment frameworks.
Why Assessing Value Is Important and Why It’s Important to Get It Right
Why is assessing value in health care important? Why is it important to do it right? These two questions were at the heart of an opening presentation that set the tone for the National Pharmaceutical…
How and Why Is Broader Exchange of Information Needed to Support Public Health and Delivery Reform?
On November 9-10, 2016, the Food and Drug Administration will host a stakeholder meeting to obtain input on how biopharmaceutical companies and others are allowed to exchange information, such as…
Accountable Care Models Offer Insights on Improving Patient Care
Treatment for chronic conditions account for most health costs in the United States. So as health care providers shift to innovative delivery models to provide value-based care while being held…
NPC Value Conference Sparks Dialogue to Define, Understand Value in Health Care
How do we measure the value of a medical intervention, its benefits to patients, and the associated costs to patients, payers and society as a whole. Hundreds of stakeholders gathered in-person and…
The Central Role of Physician Leadership for Driving Change in Value-Based Care Environments
This case study analyzing accountable care organizations looks at lessons learned from the implementation of the American Medical Group Foundation’s Measure Up/Pressure Down initiative.
Putting Patients First® in the Value Equation: An Interview With the National Health Council’s Dr. Eleanor Perfetto
National Pharmaceutical Council President Dan Leonard caught up this week with Eleanor Perfetto, PhD, MS, Senior Vice President of Strategic Initiatives at the National Health Council (NHC), about…
Health Affairs Article Highlights Benefit of Reducing Low-Value Health Care
The authors identify three areas where consensus exists to begin further efforts to reduce low-value care, improve quality and lower costs.
Optimizing the Recipe for "Health Care Spending Pie": Finding the Most Effective Resource Allocation
Despite concerns about the growth of the health care spending pie, little attention has been paid to the spending upon slices within it, such as how is the money being spent, and how well?